- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin, Isophane
Total 2806 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFormer Serbia and Montenegro
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Former Serbia and Montenegro
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFinland
-
Wake Forest University Health SciencesActive, not recruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesArgentina, Brazil
-
SanofiTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, China, India, Iran, Islamic Republic of, Korea, Republic of, Russian Federation, Poland, Japan, Italy, Canada, Greece
-
WockhardtCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
GeropharmCompletedBioequivalenceRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
National Institute of Diabetes and Digestive and...Type 1 Diabetes TrialNetCompletedType 1 DiabetesUnited States, Canada, Italy, Australia
-
Biologics & Biosimilars Collective Intelligence...Merck Sharp & Dohme LLC; Pfizer; AbbVie; University of Pittsburgh; Boehringer Ingelheim and other collaboratorsCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
IKFE Institute for Clinical Research and DevelopmentSanofi-SynthelaboCompleted
-
Heidelberg UniversityUnknown
-
SanofiCompletedType 2 Diabetes MellitusChina
-
GeropharmCompletedBioequivalence | Therapeutic EquivalencyRussian Federation
-
Xijing HospitalXi'an Central Hospital; First Affiliated Hospital Xi'an Jiaotong University; Shaanxi... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
Taipei Veterans General Hospital, TaiwanUnknown
-
Abbott Diabetes CareCompletedDiabetes MellitusUnited Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Puerto Rico, Russian Federation, United Kingdom, Denmark, France, Israel, Australia, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Russian Federation, Belgium, Spain, Israel, Croatia, Serbia, North Macedonia, South Africa, Slovenia, Brazil, Poland, Canada, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, France, Austria, Norway, Algeria
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Austria
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Tulane University Health Sciences CenterCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Russian Federation, Serbia, Turkey, Algeria, Czechia
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompleted
-
NovartisCompletedType 2 Diabetes Mellitus | Impaired Glucose ToleranceUnited States, Canada, Finland, Australia, Germany, India, Italy
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Israel, Russian Federation, Slovakia, Canada, Serbia, United Kingdom, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Finland, Belgium, Hungary, United Kingdom, Germany, Canada, Czechia
-
WockhardtCompletedDiabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, United States, India, Israel, Italy, Russian Federation, Japan, Finland, Serbia, Turkey, Bulgaria, Estonia, Czechia, Lithuania, Ukraine, Poland, Latvia, Puerto Rico
-
University of FloridaNovo Nordisk A/S; VA Office of Research and DevelopmentCompletedType 2 DiabetesUnited States
-
National Institute of Neurosciences and Hospital...Completed
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Sweden, Norway, Germany, Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Emory UniversityCompletedBenefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Malaysia, Germany, Algeria, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, France, Sweden, Poland, Turkey, Korea, Republic of, India, South Africa
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1India, Italy, United Kingdom, Finland, Japan, Argentina, Macedonia, The Former Yugoslav Republic of, Brazil
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, United Kingdom, France, Netherlands, Finland, Germany, Sweden
-
Novo Nordisk A/SCompleted